Literature DB >> 9574966

Survival analysis with uncertain endpoints.

S M Snapinn1.   

Abstract

In some survival analysis applications, the endpoint of interest has a degree of uncertainty associated with it. These events are typically classified by the investigator or by an endpoint committee as true or false according to some decision rule, and the analysis proceeds using only the true endpoints. This procedure has two drawbacks: The cut point for the decision rule is somewhat arbitrary, and the information contained in the level of certainty is lost. This paper introduces a modification of the Cox regression model that allows all potential endpoints to be included in the analysis along with the level of certainty of each. Simulation results show this procedure to considerably increase the power of the standard procedure in a wide range of situations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574966

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  Assessing treatment effects with surrogate survival outcomes using an internal validation subsample.

Authors:  Jarcy Zee; Sharon X Xie
Journal:  Clin Trials       Date:  2015-05-14       Impact factor: 2.486

2.  Methods for Employing Information About Uncertainty of Ascertainment of Events in Clinical Trials.

Authors:  Yiming Chen; John Lawrence; H M James Hung; Norman Stockbridge
Journal:  Ther Innov Regul Sci       Date:  2020-09-01       Impact factor: 1.778

3.  Cladograms with Path to Event (ClaPTE): a novel algorithm to detect associations between genotypes or phenotypes using phylogenies.

Authors:  Samuel K Handelman; Jacob M Aaronson; Michal Seweryn; Igor Voronkin; Jesse J Kwiek; Wolfgang Sadee; Joseph S Verducci; Daniel A Janies
Journal:  Comput Biol Med       Date:  2014-12-24       Impact factor: 4.589

4.  Interval-censored data with misclassification: a Bayesian approach.

Authors:  Magda Carvalho Pires; Enrico Antônio Colosimo; Guilherme Augusto Veloso; Raquel de Souza Borges Ferreira
Journal:  J Appl Stat       Date:  2020-04-16       Impact factor: 1.416

5.  Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample.

Authors:  Jarcy Zee; Sharon X Xie
Journal:  Biometrics       Date:  2015-04-27       Impact factor: 2.571

6.  Study design for non-recurring, time-to-event outcomes in the presence of error-prone diagnostic tests or self-reports.

Authors:  Xiangdong Gu; Raji Balasubramanian
Journal:  Stat Med       Date:  2016-05-18       Impact factor: 2.373

7.  Incorporating validation subsets into discrete proportional hazards models for mismeasured outcomes.

Authors:  Amalia S Magaret
Journal:  Stat Med       Date:  2008-11-20       Impact factor: 2.373

8.  SEMIPARAMETRIC TIME TO EVENT MODELS IN THE PRESENCE OF ERROR-PRONE, SELF-REPORTED OUTCOMES-WITH APPLICATION TO THE WOMEN'S HEALTH INITIATIVE.

Authors:  Xiangdong Gu; Yunsheng Ma; Raji Balasubramanian
Journal:  Ann Appl Stat       Date:  2015-06       Impact factor: 2.083

Review 9.  Statistical modeling of Huntington disease onset.

Authors:  Tanya P Garcia; Karen Marder; Yuanjia Wang
Journal:  Handb Clin Neurol       Date:  2017

10.  Bayesian variable selection for high dimensional predictors and self-reported outcomes.

Authors:  Xiangdong Gu; Mahlet G Tadesse; Andrea S Foulkes; Yunsheng Ma; Raji Balasubramanian
Journal:  BMC Med Inform Decis Mak       Date:  2020-09-07       Impact factor: 2.796

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.